{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:13:41Z","timestamp":1791443621291,"version":"4.3.3"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11231-6","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:56:45Z","timestamp":1762264605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights"],"prefix":"10.1007","volume":"53","author":[{"given":"Manjari","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoorvir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"11231_CR1","unstructured":"Breast cancer. (n.d.) https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer. Accessed August 2, 2025"},{"issue":"5","key":"11231_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x","journal-title":"Nat Med"},{"issue":"3","key":"11231_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, Hynes RO, Jain RK, Janowitz T, Jorgensen C, Kimmelman AC, Kolonin MG, Maki RG, Powers RS, Pur\u00e9 E, Werb Z (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20(3):174\u2013186. https:\/\/doi.org\/10.1038\/s41568-019-0238-1","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"11231_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"B-Z Qian","year":"2010","unstructured":"Qian B-Z, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39\u201351. https:\/\/doi.org\/10.1016\/j.cell.2010.03.014","journal-title":"Cell"},{"issue":"6282","key":"11231_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Giaccia AJ (2016) Hypoxic control of metastasis. Science 352(6282):175\u2013180. https:\/\/doi.org\/10.1126\/science.aaf4405","journal-title":"Science"},{"issue":"3","key":"11231_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148(3):399\u2013408. https:\/\/doi.org\/10.1016\/j.cell.2012.01.021","journal-title":"Cell"},{"key":"11231_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.smim.2017.12.001","volume":"36","author":"A Fischer","year":"2018","unstructured":"Fischer A, Rausell A (2018) What do primary immunodeficiencies tell Us about the essentiality\/redundancy of immune responses? Semin Immunol 36:13\u201316. https:\/\/doi.org\/10.1016\/j.smim.2017.12.001","journal-title":"Semin Immunol"},{"issue":"6478","key":"11231_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977","journal-title":"Science"},{"issue":"2","key":"11231_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1158\/2159-8290.CD-14-0650","volume":"5","author":"T Kangsamaksin","year":"2015","unstructured":"Kangsamaksin T, Murtomaki A, Kofler NM, Cuervo H, Chaudhri RA, Tattersall IW, Rosenstiel PE, Shawber CJ, Kitajewski J (2015) Notch decoys that selectively block DLL\/NOTCH or JAG\/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth. Cancer Discov 5(2):182\u2013197. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0650","journal-title":"Cancer Discov"},{"issue":"3","key":"11231_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016","journal-title":"Cancer Cell"},{"key":"11231_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753","journal-title":"Pharmacol Ther"},{"issue":"3","key":"11231_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"11231_CR13","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v5.i3.465","volume":"5","author":"K Unger-Salda\u00f1a","year":"2014","unstructured":"Unger-Salda\u00f1a K (2014) Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol 5(3):465. https:\/\/doi.org\/10.5306\/wjco.v5.i3.465","journal-title":"World J Clin Oncol"},{"issue":"5","key":"11231_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/tbj.12801","volume":"23","author":"RB Nunes","year":"2017","unstructured":"Nunes RB, Silva MFD, Coltro PS, Lima RVKS, Farina JA Jr (2017) Treatment of breast hypoplasia in Becker nevus syndrome. Breast J 23(5):603\u2013604. https:\/\/doi.org\/10.1111\/tbj.12801","journal-title":"Breast J"},{"issue":"4","key":"11231_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrc3896","volume":"15","author":"EC Dietze","year":"2015","unstructured":"Dietze EC, Sistrunk C, Miranda-Carboni G, O\u2019Regan R, Seewaldt VL (2015) Triple-negative breast cancer in African-American women: disparities versus biology. Nat Rev Cancer 15(4):248\u2013254. https:\/\/doi.org\/10.1038\/nrc3896","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"11231_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cell.2022.01.024","volume":"185","author":"M Zazhytska","year":"2022","unstructured":"Zazhytska M, Kodra A, Hoagland DA, Frere J, Fullard JF, Shayya H, McArthur NG, Moeller R, Uhl S, Omer AD, Gottesman ME, Firestein S, Gong Q, Canoll PD, Goldman JE, Roussos P, tenOever BR, Overdevest JB, Lomvardas S (2022) Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell 185(6):1052\u20131064e12. https:\/\/doi.org\/10.1016\/j.cell.2022.01.024","journal-title":"Cell"},{"issue":"6230","key":"11231_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348(6230):74\u201380. https:\/\/doi.org\/10.1126\/science.aaa6204","journal-title":"Science"},{"issue":"12","key":"11231_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","volume":"17","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi L, Humeau J, Buqu\u00e9 A, Zitvogel L, Kroemer G (2020) Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol 17(12):725\u2013741. https:\/\/doi.org\/10.1038\/s41571-020-0413-z","journal-title":"Nat Rev Clin Oncol"},{"issue":"7467","key":"11231_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, De Sauvage FJ (2013) Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501(7467):346\u2013354. https:\/\/doi.org\/10.1038\/nature12626","journal-title":"Nature"},{"issue":"6127","key":"11231_CR20","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW (2013) Cancer genome landscapes. Science 339(6127):1546\u20131558. https:\/\/doi.org\/10.1126\/science.1235122","journal-title":"Science"},{"issue":"6","key":"11231_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883\u2013899. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025","journal-title":"Cell"},{"issue":"7203","key":"11231_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444. https:\/\/doi.org\/10.1038\/nature07205","journal-title":"Nature"},{"issue":"50","key":"11231_CR23","doi-asserted-by":"publisher","first-page":"6522","DOI":"10.1038\/onc.2010.378","volume":"29","author":"JP Alameda","year":"2010","unstructured":"Alameda JP, Moreno-Maldonado R, Navarro M, Bravo A, Ram\u00edrez A, Page A, Jorcano JL, Fern\u00e1ndez-Ace\u00f1ero MJ, Casanova ML (2010) An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene 29(50):6522\u20136532. https:\/\/doi.org\/10.1038\/onc.2010.378","journal-title":"Oncogene"},{"issue":"4","key":"11231_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8040045","volume":"8","author":"D Zeitouni","year":"2016","unstructured":"Zeitouni D, Pylayeva-Gupta Y, Der C, Bryant K (2016) KRAS mutant pancreatic cancer: no lone path to an effective treatment. Cancers (Basel) 8(4):45. https:\/\/doi.org\/10.3390\/cancers8040045","journal-title":"Cancers (Basel)"},{"issue":"7637","key":"11231_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I (2017) Elements of cancer immunity and the cancer\u2013immune set point. Nature 541(7637):321\u2013330. https:\/\/doi.org\/10.1038\/nature21349","journal-title":"Nature"},{"issue":"1","key":"11231_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41467-018-08178-7","volume":"10","author":"A Sartori-Rupp","year":"2019","unstructured":"Sartori-Rupp A, Cervantes C, Pepe D, Gousset A, Delage K, Corroyer-Dulmont E, Schmitt S, Krijnse-Locker C, J., Zurzolo C (2019) Correlative cryo-electron microscopy reveals the structure of TNTs in neuronal cells. Nat Commun 10(1):1\u201316. https:\/\/doi.org\/10.1038\/S41467-018-08178-7","journal-title":"Nat Commun"},{"issue":"7381","key":"11231_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481(7381):306\u2013313. https:\/\/doi.org\/10.1038\/nature10762","journal-title":"Nature"},{"issue":"4","key":"11231_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C (2017) Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168(4):613\u2013628. https:\/\/doi.org\/10.1016\/j.cell.2017.01.018","journal-title":"Cell"},{"issue":"11","key":"11231_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"issue":"9","key":"11231_CR30","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582\u2013598. https:\/\/doi.org\/10.1038\/nrc.2016.73","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"11231_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc.2015.21","volume":"16","author":"CJ Lord","year":"2016","unstructured":"Lord CJ, Ashworth A (2016) BRCAness revisited. Nat Rev Cancer 16(2):110\u2013120. https:\/\/doi.org\/10.1038\/nrc.2015.21","journal-title":"Nat Rev Cancer"},{"key":"11231_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-017-0605-8","volume":"12","author":"M Zhang","year":"2017","unstructured":"Zhang M, Zhuang G, Sun X, Shen Y, Wang W, Li Q, Di W (2017) TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer. Diagn Pathol 12:16. https:\/\/doi.org\/10.1186\/s13000-017-0605-8","journal-title":"Diagn Pathol"},{"issue":"1","key":"11231_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1128\/MCB.23.1.206-215.2003","volume":"23","author":"Y Kondo","year":"2003","unstructured":"Kondo Y, Shen L, Issa J-PJ (2003) Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 23(1):206\u2013215. https:\/\/doi.org\/10.1128\/MCB.23.1.206-215.2003","journal-title":"Mol Cell Biol"},{"key":"11231_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W (2023) Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8:70. https:\/\/doi.org\/10.1038\/s41392-023-01332-8","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"11231_CR35","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","volume":"80","author":"AM Shiri","year":"2024","unstructured":"Shiri AM, Zhang T, Bedke T, Zazara DE, Zhao L, L\u00fccke J, Sabihi M, Fazio A, Zhang S, Tauriello DVF, Batlle E, Steglich B, Kempski J, Agalioti T, Nawrocki M, Xu Y, Riecken K, Liebold I, Brockmann L, Huber S (2024) IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction. J Hepatol 80(4):634\u2013644. https:\/\/doi.org\/10.1016\/j.jhep.2023.12.015","journal-title":"J Hepatol"},{"issue":"16","key":"11231_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163906","volume":"14","author":"RA Glabman","year":"2022","unstructured":"Glabman RA, Choyke PL, Sato N (2022) Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy. Cancers (Basel) 14(16):3906. https:\/\/doi.org\/10.3390\/cancers14163906","journal-title":"Cancers (Basel)"},{"key":"11231_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.752818","volume":"10","author":"S Bai","year":"2022","unstructured":"Bai S, Wang Z, Wang M, Li J, Wei Y, Xu R, Du J (2022) Tumor-derived exosomes modulate primary site tumor metastasis. Front Cell Dev Biol 10:752818. https:\/\/doi.org\/10.3389\/fcell.2022.752818","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"11231_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26(2):225\u2013239. https:\/\/doi.org\/10.1007\/s10555-007-9055-1","journal-title":"Cancer Metastasis Rev"},{"issue":"5930","key":"11231_CR39","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033. https:\/\/doi.org\/10.1126\/science.1160809","journal-title":"Science"},{"issue":"11","key":"11231_CR40","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.4161\/cc.9.11.11855","volume":"9","author":"RK Clyne","year":"2010","unstructured":"Clyne RK (2010) Move over: DLIC-like protein in pole position in meiosis. Cell Cycle 9(11):2059\u20132062. https:\/\/doi.org\/10.4161\/cc.9.11.11855","journal-title":"Cell Cycle"},{"issue":"5","key":"11231_CR41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V, Chouaib S (2014) PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 211(5):781\u2013790. https:\/\/doi.org\/10.1084\/jem.20131916","journal-title":"J Exp Med"},{"issue":"1","key":"11231_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01854-1","volume":"26","author":"MF Coleman","year":"2024","unstructured":"Coleman MF, Cotul EK, Pfeil AJ, Devericks EN, Safdar MH, Monteiro M, Chen H, Ho AN, Attaar N, Malian HM, Kiesel VA, Ramos A, Smith M, Panchal H, Mailloux A, Teegarden D, Hursting SD, Wendt MK (2024) Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression. Breast Cancer Res 26(1):96. https:\/\/doi.org\/10.1186\/s13058-024-01854-1","journal-title":"Breast Cancer Res"},{"issue":"5","key":"11231_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2(5):e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200","journal-title":"Sci Adv"},{"issue":"12","key":"11231_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL (2016) Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer 2(12):758\u2013770. https:\/\/doi.org\/10.1016\/j.trecan.2016.10.016","journal-title":"Trends Cancer"},{"issue":"7","key":"11231_CR45","doi-asserted-by":"publisher","first-page":"e63852","DOI":"10.7759\/cureus.63852","volume":"16","author":"M Basheeruddin","year":"2024","unstructured":"Basheeruddin M, Qausain S (2024) Hypoxia-Inducible factor 1-Alpha (HIF-1\u03b1): an essential regulator in cellular metabolic control. Cureus 16(7):e63852. https:\/\/doi.org\/10.7759\/cureus.63852","journal-title":"Cureus"},{"issue":"5","key":"11231_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051172","volume":"12","author":"H Saman","year":"2020","unstructured":"Saman H, Raza SS, Uddin S, Rasul K (2020) Inducing angiogenesis, a key step in cancer vascularization, and treatment approaches. Cancers (Basel) 12(5):1172. https:\/\/doi.org\/10.3390\/cancers12051172","journal-title":"Cancers (Basel)"},{"issue":"6","key":"11231_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03985","volume":"6","author":"T Kido","year":"2020","unstructured":"Kido T, Murata H, Nishigaki A, Tsubokura H, Komiya S, Kida N, Kakita-Kobayashi M, Hisamatsu Y, Tsuzuki T, Hashimoto Y, Okada H (2020) Glucose transporter 1 is important for the glycolytic metabolism of human endometrial stromal cells in hypoxic environment. Heliyon 6(6):e03985. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03985","journal-title":"Heliyon"},{"issue":"11","key":"11231_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113244","volume":"12","author":"R P\u00e9rez-Tom\u00e1s","year":"2020","unstructured":"P\u00e9rez-Tom\u00e1s R, P\u00e9rez-Guill\u00e9n I (2020) Lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers (Basel) 12(11):3244. https:\/\/doi.org\/10.3390\/cancers12113244","journal-title":"Cancers (Basel)"},{"key":"11231_CR49","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.2147\/OTT.S150817","volume":"11","author":"E Grywalska","year":"2018","unstructured":"Grywalska E, Pasiarski M, G\u00f3\u017ad\u017a S, Roli\u0144ski J (2018) Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer. OncoTargets Therapy 11:6505. https:\/\/doi.org\/10.2147\/OTT.S150817","journal-title":"OncoTargets Therapy"},{"issue":"2","key":"11231_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","volume":"122","author":"HM Becker","year":"2020","unstructured":"Becker HM (2020) Carbonic anhydrase IX and acid transport in cancer. Br J Cancer 122(2):157\u2013167. https:\/\/doi.org\/10.1038\/s41416-019-0642-z","journal-title":"Br J Cancer"},{"issue":"9","key":"11231_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091083","volume":"8","author":"MZ Noman","year":"2019","unstructured":"Noman MZ, Hasmim M, Lequeux A, Xiao M, Duhem C, Chouaib S, Berchem G, Janji B (2019) Improving cancer immunotherapy by targeting the hypoxic tumor microenvironment: new opportunities and challenges. Cells 8(9):1083. https:\/\/doi.org\/10.3390\/cells8091083","journal-title":"Cells"},{"key":"11231_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/ITT.S55415","volume":"4","author":"TL Whiteside","year":"2015","unstructured":"Whiteside TL (2015) The role of regulatory T cells in cancer immunology. Immunotargets Therapy 4:159\u2013171. https:\/\/doi.org\/10.2147\/ITT.S55415","journal-title":"Immunotargets Therapy"},{"issue":"3","key":"11231_CR53","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI (2016) The nature of Myeloid-Derived suppressor cells in the tumor microenvironment. Trends Immunol 37(3):208\u2013220. https:\/\/doi.org\/10.1016\/j.it.2016.01.004","journal-title":"Trends Immunol"},{"issue":"7","key":"11231_CR54","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14(7):399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"11231_CR55","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu Y-X (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14(10):1014\u20131022. https:\/\/doi.org\/10.1038\/ni.2703","journal-title":"Nat Immunol"},{"issue":"5","key":"11231_CR56","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, Ghajar CM, Lyden D (2017) Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer 17(5):302\u2013317. https:\/\/doi.org\/10.1038\/nrc.2017.6","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"11231_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY-J, Jackson RA, Thiery JP (2016) EMT: 2016. Cell 166(1):21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"issue":"12","key":"11231_CR58","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","volume":"2","author":"M Labelle","year":"2012","unstructured":"Labelle M, Hynes RO (2012) The initial hours of metastasis: the importance of cooperative host\u2013tumor cell interactions during hematogenous dissemination. Cancer Discov 2(12):1091\u20131099. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0329","journal-title":"Cancer Discov"},{"issue":"7578","key":"11231_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Lyden D (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527(7578):329\u2013335. https:\/\/doi.org\/10.1038\/nature15756","journal-title":"Nature"},{"issue":"4","key":"11231_CR60","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","volume":"25","author":"W Zhou","year":"2014","unstructured":"Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O\u2019Connor STF, Chin AR, Yen Y, Wang Y, Marcusson EG, Chu P, Wu J, Wu X, Li AX, Li Z, Gao H, Wang SE (2014) Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25(4):501\u2013515. https:\/\/doi.org\/10.1016\/j.ccr.2014.03.007","journal-title":"Cancer Cell"},{"issue":"7069","key":"11231_CR61","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D (2005) VEGFR1-positive Haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820\u2013827. https:\/\/doi.org\/10.1038\/nature04186","journal-title":"Nature"},{"issue":"8","key":"11231_CR62","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2217\/fon.09.90","volume":"5","author":"MK Wendt","year":"2009","unstructured":"Wendt MK, Allington TM, Schiemann WP (2009) Mechanisms of Epithelial-Mesenchymal transition by TGF-\u03b2. Future Oncol (London England) 5(8):1145\u20131168. https:\/\/doi.org\/10.2217\/fon.09.90","journal-title":"Future Oncol (London England)"},{"issue":"2","key":"11231_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cvr\/cvq105","volume":"87","author":"DO Bates","year":"2010","unstructured":"Bates DO (2010) Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87(2):262\u2013271. https:\/\/doi.org\/10.1093\/cvr\/cvq105","journal-title":"Cardiovasc Res"},{"key":"11231_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1187741","volume":"14","author":"H Zhou","year":"2023","unstructured":"Zhou H, Zhao C, Shao R, Xu Y, Zhao W (2023) The functions and regulatory pathways of S100A8\/A9 and its receptors in cancers. Front Pharmacol 14:1187741. https:\/\/doi.org\/10.3389\/fphar.2023.1187741","journal-title":"Front Pharmacol"},{"issue":"10","key":"11231_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13115","volume":"54","author":"M Xu","year":"2021","unstructured":"Xu M, Wang Y, Xia R, Wei Y, Wei X (2021) Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting. Cell Prolif 54(10):e13115. https:\/\/doi.org\/10.1111\/cpr.13115","journal-title":"Cell Prolif"},{"issue":"5","key":"11231_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050729","volume":"11","author":"PG Amendola","year":"2019","unstructured":"Amendola PG, Reuten R, Erler JT (2019) Interplay between LOX enzymes and integrins in the tumor microenvironment. Cancers (Basel) 11(5):729. https:\/\/doi.org\/10.3390\/cancers11050729","journal-title":"Cancers (Basel)"},{"issue":"6","key":"11231_CR67","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrc1367","volume":"4","author":"JM Brown","year":"2004","unstructured":"Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4(6):437\u2013447. https:\/\/doi.org\/10.1038\/nrc1367","journal-title":"Nat Rev Cancer"},{"key":"11231_CR68","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.semcancer.2014.07.002","volume":"31","author":"R Salgado","year":"2015","unstructured":"Salgado R, Aftimos P, Sotiriou C, Desmedt C (2015) Evolving paradigms in multifocal breast cancer. Semin Cancer Biol 31:111\u2013118. https:\/\/doi.org\/10.1016\/j.semcancer.2014.07.002","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"11231_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10585-008-9209-8","volume":"26","author":"JT Erler","year":"2009","unstructured":"Erler JT, Weaver VM (2009) Three-dimensional context regulation of metastasis. Clin Exp Metastasis 26(1):35\u201349. https:\/\/doi.org\/10.1007\/s10585-008-9209-8","journal-title":"Clin Exp Metastasis"},{"issue":"9","key":"11231_CR70","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-07-5480","volume":"68","author":"N Shafee","year":"2008","unstructured":"Shafee N, Smith CR, Wei S, Kim Y, Mills GB, Hortobagyi GN, Stanbridge EJ, Lee EY-HP (2008) Cancer stem cells contribute to cisplatin resistance in Brca1\/p53-mediated mouse mammary tumors. Cancer Res 68(9):3243\u20133250. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5480","journal-title":"Cancer Res"},{"key":"11231_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02176-8","volume":"23","author":"M Jin","year":"2024","unstructured":"Jin M, Fang J, Peng J, Wang X, Xing P, Jia K, Hu J, Wang D, Ding Y, Wang X, Li W, Chen Z (2024) PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies. Mol Cancer 23:266. https:\/\/doi.org\/10.1186\/s12943-024-02176-8","journal-title":"Mol Cancer"},{"issue":"1","key":"11231_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14010094","volume":"14","author":"EN Mendoza","year":"2025","unstructured":"Mendoza EN, Ciriolo MR, Ciccarone F (2025) Hypoxia-induced reactive oxygen species: their role in cancer resistance and emerging therapies to overcome it. Antioxidants 14(1):94. https:\/\/doi.org\/10.3390\/antiox14010094","journal-title":"Antioxidants"},{"issue":"1","key":"11231_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B (2025) Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol 14(1):54. https:\/\/doi.org\/10.1186\/s40164-025-00647-2","journal-title":"Exp Hematol Oncol"},{"key":"11231_CR74","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.2147\/IJN.S504649","volume":"20","author":"R Zhao","year":"2025","unstructured":"Zhao R, Ma L, Li J, Liu S, Yang D, Liu G, Yang S (2025) Adipose tissue-derived exosome maintains metabolic balance of extracellular matrix in rat nucleus pulposus cells. Int J Nanomed 20:2411\u20132425. https:\/\/doi.org\/10.2147\/IJN.S504649","journal-title":"Int J Nanomed"},{"issue":"1","key":"11231_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M (2025) Cancer-associated fibroblasts in cancer development and therapy. J Hematol Oncol 18(1):36. https:\/\/doi.org\/10.1186\/s13045-025-01688-0","journal-title":"J Hematol Oncol"},{"issue":"1","key":"11231_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00505-7","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Luo Y, Rao D, Wang T, Lei Z, Chen X, Zhang B, Li Y, Liu B, Xia L, Huang W (2024) Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion. Exp Hematol Oncol 13(1):39. https:\/\/doi.org\/10.1186\/s40164-024-00505-7","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"11231_CR77","first-page":"727","volume":"10","author":"Y Han","year":"2020","unstructured":"Han Y, Liu D, Li L (2020) PD-1\/PD-L1 pathway: current researches in cancer. Am J Cancer Res 10(3):727\u2013742","journal-title":"Am J Cancer Res"},{"issue":"5","key":"11231_CR78","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"23","key":"11231_CR79","doi-asserted-by":"publisher","first-page":"16771","DOI":"10.3390\/ijms242316771","volume":"24","author":"MA Dom\u00ednguez-Cejudo","year":"2023","unstructured":"Dom\u00ednguez-Cejudo MA, Gil-Torralvo A, Cejuela M, Molina-Pinelo S, Bofill S, J (2023) Targeting the tumor microenvironment in breast cancer: prognostic and predictive significance and therapeutic opportunities. Int J Mol Sci 24(23):16771. https:\/\/doi.org\/10.3390\/ijms242316771","journal-title":"Int J Mol Sci"},{"issue":"6","key":"11231_CR80","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","volume":"174","author":"L Keren","year":"2018","unstructured":"Keren L, Bosse M, Marquez D, Angoshtari R, Jain S, Varma S, Yang S-R, Kurian A, Van Valen D, West R, Bendall SC, Angelo M (2018) A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging. Cell 174(6):1373-1387e19. https:\/\/doi.org\/10.1016\/j.cell.2018.08.039","journal-title":"Cell"},{"issue":"1","key":"11231_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41(1):49\u201361. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.010","journal-title":"Immunity"},{"issue":"1","key":"11231_CR82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich DI (2017) Myeloid-derived suppressor cells. Cancer Immunol Res 5(1):3\u20138. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0297","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"11231_CR83","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H (2019) Regulatory T cells in cancer immunosuppression\u2014implications for anticancer therapy. Nat Rev Clin Oncol 16(6):356\u2013371. https:\/\/doi.org\/10.1038\/s41571-019-0175-7","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"11231_CR84","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","volume":"26","author":"RK Jain","year":"2014","unstructured":"Jain RK (2014) Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26(5):605\u2013622. https:\/\/doi.org\/10.1016\/j.ccell.2014.10.006","journal-title":"Cancer Cell"},{"issue":"35","key":"11231_CR85","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","volume":"34","author":"NM Iyengar","year":"2016","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA (2016) Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol 34(35):4270\u20134276. https:\/\/doi.org\/10.1200\/JCO.2016.67.4283","journal-title":"J Clin Oncol"},{"issue":"12","key":"11231_CR86","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15(12):1243\u20131253. https:\/\/doi.org\/10.15252\/embr.201439246","journal-title":"EMBO Rep"},{"issue":"6","key":"11231_CR87","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, Garc\u00eda-Santos G, Williams C, Ararso Y, Huang Y, Rodrigues G, Shen T-L, Labori KJ, Lothe IM, Kure EH, Hernandez J, Doussot A, Ebbesen SH, Grandgenett PM, Hollingsworth MA, Jain M, Mallya K, Batra SK, Jarnagin WR, Schwartz RE, Matei I, Peinado H, Stanger BZ, Bromberg J, Lyden D (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17(6):816\u2013826. https:\/\/doi.org\/10.1038\/ncb3169","journal-title":"Nat Cell Biol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11231-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11231-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11231-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:56:48Z","timestamp":1762264608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11231-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11231"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11231-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}